Literature DB >> 28306387

Help is on the way: Monoclonal antibody therapy for multi-drug resistant bacteria.

Rachelle Babb1, Liise-Anne Pirofski1.   

Abstract

Keywords:  Fc receptor; Gram negative organisms; Klebsiella pneumoniae; antibiotic resistance; drug resistant; monoclonal antibody therapy

Mesh：

Substances：

Year:  2017        PMID： 28306387      PMCID： PMC5711430          DOI： 10.1080/21505594.2017.1306620

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  27 in total

1.  Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.

Authors:  S Johnson; C Oliver; G A Prince; V G Hemming; D S Pfarr; S C Wang; M Dormitzer; J O'Grady; S Koenig; J K Tamura; R Woods; G Bansal; D Couchenour; E Tsao; W C Hall; J F Young
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

2.  Mouse model recapitulating human Fcγ receptor structural and functional diversity.

Authors:  Patrick Smith; David J DiLillo; Stylianos Bournazos; Fubin Li; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

3.  Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.

Authors:  Elizabeth Diago-Navarro; Isabel Calatayud-Baselga; Donglei Sun; Camille Khairallah; Inderjit Mann; Amaia Ulacia-Hernando; Brian Sheridan; Meiqing Shi; Bettina C Fries
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

4.  Both clades of the epidemic KPC-producing Klebsiella pneumoniae clone ST258 share a modified galactan O-antigen type.

Authors:  Valéria Szijártó; Luis Miguel Guachalla; Katharina Hartl; Cecília Varga; Pallavi Banerjee; Katarina Stojkovic; Marta Kaszowska; Eszter Nagy; Jolanta Lukasiewicz; Gábor Nagy
Journal:  Int J Med Microbiol       Date:  2015-12-15       Impact factor: 3.473

5.  A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.

Authors:  Sarah Weber; Haijun Tian; Nico van Rooijen; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

6.  Treatment with monoclonal antibodies against Clostridium difficile toxins.

Authors:  Israel Lowy; Deborah C Molrine; Brett A Leav; Barbra M Blair; Roger Baxter; Dale N Gerding; Geoffrey Nichol; William D Thomas; Mark Leney; Susan Sloan; Catherine A Hay; Donna M Ambrosino
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

7.  Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258.

Authors:  Valéria Szijártó; Luis M Guachalla; Katharina Hartl; Cecília Varga; Adriana Badarau; Irina Mirkina; Zehra C Visram; Lukas Stulik; Christine A Power; Eszter Nagy; Gábor Nagy
Journal:  Virulence       Date:  2017-01-19       Impact factor: 5.882

Review 8.  Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases.

Authors:  Michela Flego; Alessandro Ascione; Maurizio Cianfriglia; Stefano Vella
Journal:  BMC Med       Date:  2013-01-04       Impact factor: 8.775

9.  "Stormy waters ahead": global emergence of carbapenemases.

Authors:  Gopi Patel; Robert A Bonomo
Journal:  Front Microbiol       Date:  2013-03-14       Impact factor: 5.640

10.  Antibody blocks acquisition of bacterial colonization through agglutination.

Authors:  A M Roche; A L Richard; J T Rahkola; E N Janoff; J N Weiser
Journal:  Mucosal Immunol       Date:  2014-06-25       Impact factor: 7.313
View more
  6 in total

1.  A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.

Authors:  Madeline R Galac; Erik Snesrud; Francois Lebreton; Jason Stam; Michael Julius; Ana C Ong; Rosslyn Maybank; Anthony R Jones; Yoon I Kwak; Kate Hinkle; Paige E Waterman; Emil P Lesho; Jason W Bennett; Patrick Mc Gann
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Intradermal Immunization with Heat-Killed Klebsiella pneumoniae Leading to the Production of Protective Immunoglobulin G in BALB/c Mice.

Authors:  Zannat Kawser; S M Shamsuzzaman
Journal:  Int J Appl Basic Med Res       Date:  2021-07-19

3.  Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections.

Authors:  Byungji Kim; Qinglin Yang; Leslie W Chan; Sangeeta N Bhatia; Erkki Ruoslahti; Michael J Sailor
Journal:  Nanoscale Horiz       Date:  2021-02-18       Impact factor: 10.989

4.  Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection.

Authors:  Travis B Nielsen; Jun Yan; Brian M Luna; Yuli Talyansky; Matthew Slarve; Robert A Bonomo; Brad Spellberg
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 7.759

Review 5.  Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria.

Authors:  Abid Ali Khan; Khanzadi Nazneen Manzoor; Aamir Sultan; Maria Saeed; Mahrukh Rafique; Sameen Noushad; Ayesha Talib; Simone Rentschler; Hans-Peter Deigner
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

6.  Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse Model.

Authors:  Litty Babu; Siva R Uppalapati; Murali H Sripathy; Prakash N Reddy
Journal:  Front Microbiol       Date:  2017-09-20       Impact factor: 5.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.